Marco Valgimigli - Concepedia

Author

Marco Valgimigli

Also Known As

Andrea Rubboli, Andrzej Surdacki, Authors:, Autores/miembros del Grupo de Trabajo: Marco Valgimigli, Bart P Van Putte, Christian Mueller, Davide Capodanno, Denis Xavier, Dik Heg, Doron Zahger

1.3K

Publications

148.3K

Citations

131

H-Index

145

Concepts

All Affiliations

University Hospital of Bern Erasmus University Rotterdam University of Bern University of Ferrara Erasmus MC

About

Marco Valgimigli is an author at University Hospital of Bern specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	69	180	31K
2	Health Sciences	11	12	855
3	Engineering	5	5	496
4	Natural Sciences	2	2	32
5	Education	1	1	13

Marco Valgimigli

385

Publications

69.5K

Citations

H-Index

Page 1

	Year	Citations
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Borja Ibáñez, Stefan James, Stefan Agewall, European Heart Journal Evidence-based MedicineClinical GuidelinesCoronary Artery DiseaseAcute Myocardial InfarctionThrombosis	2017	9.5K
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Marco Roffi, Carlo Patrono, Jean‐Philippe Collet, European Heart Journal	2015	8.2K
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes Juhani Knuuti, William Wijns, Antti Saraste, European Heart Journal	2019	6.9K
Standardized Bleeding Definitions for Cardiovascular Clinical Trials Roxana Mehran, Sunil V. Rao, Deepak L. Bhatt, Circulation ThrombosisBleeding DefinitionsCardiovascular DiseaseAtherosclerosisCoronary Artery Disease	2011	4.3K
2014 ESC/EACTS Guidelines on myocardial revascularization Philippe Kolh, Stephan Windecker, Fernándo Alfonso, European Journal of Cardio-Thoracic Surgery	2014	4.2K
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS Marco Valgimigli, Héctor Bueno, Robert A. Byrne, European Heart Journal	2017	2.9K
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial Marco Valgimigli, Andrea Gagnor, Paolo Calabrò, The Lancet Percutaneous Coronary InterventionCardiovascular DiseaseCoronary Artery DiseasePatient SafetyVascular Surgery	2015	1.3K
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial Pascal Vranckx, Marco Valgimigli, Peter Jüni, The Lancet Endovascular TechniqueCardiovascular DiseaseRandomised Superiority TrialLumen-apposing Metal StentPharmacotherapy	2018	761
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes Pierluigi Tricoci, Zhen Huang, Claes Held, New England Journal of Medicine	2011	747
Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting Marco Valgimigli, Gianluca Campo, Monia Monti, Circulation	2012	667

Page 1